SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1har'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FK9_A_EFZA999_1 (HIV-1 RT, A-CHAIN)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	LYS A 104 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.94A	1fk9A-1harA: 26.8	1fk9A-1harA: 94.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1FKP_A_NVPA999_1 (HIV-1 RT, A-CHAIN)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 11	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.48A	1fkpA-1harA: 13.2	1fkpA-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LW0_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.53A	1lw0A-1harA: 26.4	1lw0A-1harA: 43.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWC_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 11	LYS A 104 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	1.00A	1lwcA-1harA: 24.3	1lwcA-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWC_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 11	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.55A	1lwcA-1harA: 24.3	1lwcA-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWE_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	VAL A 106 TYR A 181 TYR A 188 GLY A 190	None	0.50A	1lweA-1harA: 23.1	1lweA-1harA: 42.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1LWF_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 9	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.54A	1lwfA-1harA: 13.1	1lwfA-1harA: 42.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S1U_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.52A	1s1uA-1harA: 26.5	1s1uA-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1S1X_A_NVPA999_1 (REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	VAL A 106 TYR A 181 TYR A 188 GLY A 190	None	0.51A	1s1xA-1harA: 12.0	1s1xA-1harA: 93.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_J_CHDJ3060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	1v54A-1harA: undetectable 1v54J-1harA: 0.0	1v54A-1harA: 18.00 1v54J-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.75A	1v54N-1harA: undetectable 1v54W-1harA: 0.1	1v54N-1harA: 18.00 1v54W-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_J_CHDJ3060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.66A	1v55A-1harA: undetectable 1v55J-1harA: 0.1	1v55A-1harA: 18.00 1v55J-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V55_W_CHDW4060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.70A	1v55N-1harA: undetectable 1v55W-1harA: 0.1	1v55N-1harA: 18.00 1v55W-1harA: 13.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1VRT_A_NVPA999_1 (HIV-1 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 9	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.50A	1vrtA-1harA: 26.8	1vrtA-1harA: 94.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.71A	2dyrA-1harA: undetectable 2dyrJ-1harA: 0.1	2dyrA-1harA: 18.00 2dyrJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYR_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.74A	2dyrN-1harA: undetectable 2dyrW-1harA: 0.0	2dyrN-1harA: 18.00 2dyrW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_J_CHDJ101_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	2dysA-1harA: undetectable 2dysJ-1harA: 0.1	2dysA-1harA: 18.00 2dysJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2DYS_W_CHDW101_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.74A	2dysN-1harA: undetectable 2dysW-1harA: 0.1	2dysN-1harA: 18.00 2dysW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.69A	2eijA-1harA: undetectable 2eijJ-1harA: 0.1	2eijA-1harA: 18.00 2eijJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIJ_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.68A	2eijN-1harA: undetectable 2eijW-1harA: 0.1	2eijN-1harA: 18.00 2eijW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.67A	2eikA-1harA: undetectable 2eikJ-1harA: 0.0	2eikA-1harA: 18.00 2eikJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIK_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.70A	2eikN-1harA: undetectable 2eikW-1harA: 0.0	2eikN-1harA: 18.00 2eikW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.71A	2eilA-1harA: undetectable 2eilJ-1harA: 0.0	2eilA-1harA: 18.00 2eilJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIL_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	2eilN-1harA: undetectable 2eilW-1harA: 0.0	2eilN-1harA: 18.00 2eilW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.79A	2einA-1harA: undetectable 2einJ-1harA: 0.1	2einA-1harA: 18.00 2einJ-1harA: 13.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HND_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.50A	2hndA-1harA: 26.7	2hndA-1harA: 92.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HNY_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	LYS A 104 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	1.00A	2hnyA-1harA: 26.6	2hnyA-1harA: 92.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HNY_A_NVPA999_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.53A	2hnyA-1harA: 26.6	2hnyA-1harA: 92.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OIP_D_MTXD617_1 (CHAIN A, CRYSTAL STRUCTURE OF DHFR)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 12	ALA A 158 LEU A 149 PHE A 160 ILE A 5 LEU A 214	None	1.15A	2oipD-1harA: undetectable	2oipD-1harA: 17.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.77A	2zxwA-1harA: undetectable 2zxwJ-1harA: 0.0	2zxwA-1harA: 18.00 2zxwJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	3abkA-1harA: undetectable 3abkJ-1harA: 0.1	3abkA-1harA: 18.00 3abkJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.75A	3ablA-1harA: undetectable 3ablJ-1harA: 0.0	3ablA-1harA: 18.00 3ablJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABL_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.71A	3ablN-1harA: undetectable 3ablW-1harA: 0.0	3ablN-1harA: 18.00 3ablW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	3abmA-1harA: undetectable 3abmJ-1harA: 0.0	3abmA-1harA: 18.00 3abmJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABM_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	3abmN-1harA: undetectable 3abmW-1harA: 0.0	3abmN-1harA: 18.00 3abmW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_J_CHDJ60_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	3ag3A-1harA: undetectable 3ag3J-1harA: 0.0	3ag3A-1harA: 18.00 3ag3J-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_W_CHDW1059_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.79A	3ag3N-1harA: undetectable 3ag3W-1harA: 0.1	3ag3N-1harA: 18.00 3ag3W-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_J_CHDJ60_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.73A	3asnA-1harA: undetectable 3asnJ-1harA: 0.1	3asnA-1harA: 18.00 3asnJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_W_CHDW1059_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.74A	3asnN-1harA: undetectable 3asnW-1harA: 0.1	3asnN-1harA: 18.00 3asnW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_J_CHDJ60_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	3asoA-1harA: undetectable 3asoJ-1harA: 0.1	3asoA-1harA: 18.00 3asoJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_W_CHDW1059_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.71A	3asoN-1harA: undetectable 3asoW-1harA: 0.0	3asoN-1harA: 18.00 3asoW-1harA: 13.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HVT_A_NVPA557_1 (HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66))	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 9	LYS A 104 VAL A 106 TYR A 181 TYR A 188 GLY A 190	None	1.07A	3hvtA-1harA: 24.3	3hvtA-1harA: 94.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LP0_A_NVPA701_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 9	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.62A	3lp0A-1harA: 27.0	3lp0A-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LP1_A_NVPA701_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.65A	3lp1A-1harA: 27.5	3lp1A-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MEC_A_65BA561_0 (P66 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 12	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.68A	3mecA-1harA: 13.0	3mecA-1harA: 94.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3MED_A_65BA561_0 (P51 REVERSE TRANSCRIPTASE P66 REVERSE TRANSCRIPTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 12	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.68A	3medA-1harA: 27.7 3medB-1harA: 10.3	3medA-1harA: 93.98 3medB-1harA: 93.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QIP_A_NVPA561_1 (REVERSE HIV-1 REVERSE TRANSCRIPTASE P66)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	LYS A 104 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.97A	3qipA-1harA: 12.6	3qipA-1harA: 94.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3QIP_A_NVPA561_1 (REVERSE HIV-1 REVERSE TRANSCRIPTASE P66)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.51A	3qipA-1harA: 12.6	3qipA-1harA: 94.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TJ7_C_ACTC610_0 (GBAA_1210 PROTEIN)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	3 / 3	ASN A 54 ALA A 129 ARG A 143	None	0.88A	3tj7C-1harA: 0.0 3tj7D-1harA: 0.0	3tj7C-1harA: 19.57 3tj7D-1harA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4DO3_B_0LAB602_1 (FATTY-ACID AMIDE HYDROLASE 1)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 168 LEU A 205 ILE A 202 THR A 216	None	0.90A	4do3B-1harA: 0.9	4do3B-1harA: 17.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4J7U_D_YTZD802_1 (SEPIAPTERIN REDUCTASE)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 34 CYH A 38 TYR A 144 PRO A 133	None	1.20A	4j7uD-1harA: undetectable	4j7uD-1harA: 20.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PUO_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	VAL A 106 VAL A 179 TYR A 181 TYR A 188	None	0.57A	4puoC-1harA: 21.4	4puoC-1harA: 94.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PWD_A_NVPA901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	VAL A 106 VAL A 179 TYR A 181 TYR A 188	None	0.54A	4pwdA-1harA: 21.6	4pwdA-1harA: 94.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4PWD_C_NVPC901_1 (HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	VAL A 106 VAL A 179 TYR A 181 TYR A 188	None	0.59A	4pwdC-1harA: 12.4	4pwdC-1harA: 94.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_J_CHDJ102_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.70A	5b1aA-1harA: undetectable 5b1aJ-1harA: 0.1	5b1aA-1harA: 18.00 5b1aJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	5b1bA-1harA: undetectable 5b1bJ-1harA: 0.1	5b1bA-1harA: 18.00 5b1bJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B3S_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.73A	5b3sA-1harA: undetectable 5b3sJ-1harA: 0.1	5b3sA-1harA: 18.00 5b3sJ-1harA: 13.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HBM_A_NVPA601_1 (REVERSE TRANSCRIPTASE/RIBONU CLEASE H)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	6 / 11	LYS A 104 VAL A 106 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.88A	5hbmA-1harA: 27.5	5hbmA-1harA: 94.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.73A	5iy5A-1harA: undetectable 5iy5J-1harA: 0.1	5iy5A-1harA: 18.00 5iy5J-1harA: 13.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V0V_A_8QSA615_1 (SERUM ALBUMIN)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 HIS A 198 LEU A 168 ILE A 178	None	0.95A	5v0vA-1harA: 0.3	5v0vA-1harA: 15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 6	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.76A	5x1fA-1harA: undetectable 5x1fJ-1harA: 0.2	5x1fA-1harA: 18.00 5x1fJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.95A	5xdqN-1harA: undetectable 5xdqW-1harA: 0.0	5xdqN-1harA: 18.00 5xdqW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.75A	5xdxA-1harA: undetectable 5xdxJ-1harA: 0.1	5xdxA-1harA: 18.00 5xdxJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	5xdxN-1harA: undetectable 5xdxW-1harA: 0.0	5xdxN-1harA: 18.00 5xdxW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.73A	5zcoA-1harA: undetectable 5zcoJ-1harA: 0.1	5zcoA-1harA: 18.00 5zcoJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	5zcpA-1harA: undetectable 5zcpJ-1harA: 0.1	5zcpA-1harA: 18.00 5zcpJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.74A	5zcpN-1harA: undetectable 5zcpW-1harA: 0.1	5zcpN-1harA: 18.00 5zcpW-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.70A	5zcqA-1harA: undetectable 5zcqJ-1harA: 0.1	5zcqA-1harA: 18.00 5zcqJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCQ_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 8	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.72A	5zcqN-1harA: undetectable 5zcqW-1harA: 0.1	5zcqN-1harA: 18.00 5zcqW-1harA: 13.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSG_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	LYS A 104 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	0.87A	6bsgA-1harA: 26.1	6bsgA-1harA: 91.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	6BSI_A_EFZA601_1 (REVERSE TRANSCRIPTASE P66 SUBUNIT)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	5 / 10	LYS A 104 VAL A 179 TYR A 181 TYR A 188 GLY A 190	None	1.10A	6bsiA-1harA: 24.0	6bsiA-1harA: 91.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMF_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.87A	6nmfA-1harA: undetectable 6nmfJ-1harA: 0.1	6nmfA-1harA: 18.00 6nmfJ-1harA: 13.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6NMP_J_CHDJ101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	1har	HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS) (Human immunodeficiency virus 1)	4 / 7	LEU A 109 MET A 164 THR A 165 LEU A 168	None	0.96A	6nmpA-1harA: undetectable 6nmpJ-1harA: 0.1	6nmpA-1harA: 18.00 6nmpJ-1harA: 13.37

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FK9_A_EFZA999_1","HIV-1 RT, A-CHAIN","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.94A","1fk9A-1harA:26.8","1fk9A-1harA:94.44"],["1FKP_A_NVPA999_1","HIV-1 RT, A-CHAIN","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.48A","1fkpA-1harA:13.2","1fkpA-1harA:93.98"],["1LW0_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.53A","1lw0A-1harA:26.4","1lw0A-1harA:43.13"],["1LWC_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","1.00A","1lwcA-1harA:24.3","1lwcA-1harA:93.98"],["1LWC_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.55A","1lwcA-1harA:24.3","1lwcA-1harA:93.98"],["1LWE_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"VAL A 106;TYR A 181;TYR A 188;GLY A 190","None","0.50A","1lweA-1harA:23.1","1lweA-1harA:42.92"],["1LWF_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.54A","1lwfA-1harA:13.1","1lwfA-1harA:42.28"],["1S1U_A_NVPA999_1","REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.52A","1s1uA-1harA:26.5","1s1uA-1harA:93.98"],["1S1X_A_NVPA999_1","REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"VAL A 106;TYR A 181;TYR A 188;GLY A 190","None","0.51A","1s1xA-1harA:12.0","1s1xA-1harA:93.98"],["1V54_J_CHDJ3060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","1v54A-1harA:undetectable;1v54J-1harA:0.0","1v54A-1harA:18.00;1v54J-1harA:13.37"],["1V54_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.75A","1v54N-1harA:undetectable;1v54W-1harA:0.1","1v54N-1harA:18.00;1v54W-1harA:13.37"],["1V55_J_CHDJ3060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.66A","1v55A-1harA:undetectable;1v55J-1harA:0.1","1v55A-1harA:18.00;1v55J-1harA:13.37"],["1V55_W_CHDW4060_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.70A","1v55N-1harA:undetectable;1v55W-1harA:0.1","1v55N-1harA:18.00;1v55W-1harA:13.37"],["1VRT_A_NVPA999_1","HIV-1 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.50A","1vrtA-1harA:26.8","1vrtA-1harA:94.44"],["2DYR_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.71A","2dyrA-1harA:undetectable;2dyrJ-1harA:0.1","2dyrA-1harA:18.00;2dyrJ-1harA:13.37"],["2DYR_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.74A","2dyrN-1harA:undetectable;2dyrW-1harA:0.0","2dyrN-1harA:18.00;2dyrW-1harA:13.37"],["2DYS_J_CHDJ101_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","2dysA-1harA:undetectable;2dysJ-1harA:0.1","2dysA-1harA:18.00;2dysJ-1harA:13.37"],["2DYS_W_CHDW101_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.74A","2dysN-1harA:undetectable;2dysW-1harA:0.1","2dysN-1harA:18.00;2dysW-1harA:13.37"],["2EIJ_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.69A","2eijA-1harA:undetectable;2eijJ-1harA:0.1","2eijA-1harA:18.00;2eijJ-1harA:13.37"],["2EIJ_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.68A","2eijN-1harA:undetectable;2eijW-1harA:0.1","2eijN-1harA:18.00;2eijW-1harA:13.37"],["2EIK_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.67A","2eikA-1harA:undetectable;2eikJ-1harA:0.0","2eikA-1harA:18.00;2eikJ-1harA:13.37"],["2EIK_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.70A","2eikN-1harA:undetectable;2eikW-1harA:0.0","2eikN-1harA:18.00;2eikW-1harA:13.37"],["2EIL_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.71A","2eilA-1harA:undetectable;2eilJ-1harA:0.0","2eilA-1harA:18.00;2eilJ-1harA:13.37"],["2EIL_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","2eilN-1harA:undetectable;2eilW-1harA:0.0","2eilN-1harA:18.00;2eilW-1harA:13.37"],["2EIN_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.79A","2einA-1harA:undetectable;2einJ-1harA:0.1","2einA-1harA:18.00;2einJ-1harA:13.37"],["2HND_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.50A","2hndA-1harA:26.7","2hndA-1harA:92.59"],["2HNY_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","1.00A","2hnyA-1harA:26.6","2hnyA-1harA:92.59"],["2HNY_A_NVPA999_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.53A","2hnyA-1harA:26.6","2hnyA-1harA:92.59"],["2OIP_D_MTXD617_1","CHAIN A, CRYSTAL STRUCTURE OF DHFR","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"ALA A 158;LEU A 149;PHE A 160;ILE A   5;LEU A 214","None","1.15A","2oipD-1harA:undetectable","2oipD-1harA:17.05"],["2ZXW_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.77A","2zxwA-1harA:undetectable;2zxwJ-1harA:0.0","2zxwA-1harA:18.00;2zxwJ-1harA:13.37"],["3ABK_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","3abkA-1harA:undetectable;3abkJ-1harA:0.1","3abkA-1harA:18.00;3abkJ-1harA:13.37"],["3ABL_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.75A","3ablA-1harA:undetectable;3ablJ-1harA:0.0","3ablA-1harA:18.00;3ablJ-1harA:13.37"],["3ABL_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.71A","3ablN-1harA:undetectable;3ablW-1harA:0.0","3ablN-1harA:18.00;3ablW-1harA:13.37"],["3ABM_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","3abmA-1harA:undetectable;3abmJ-1harA:0.0","3abmA-1harA:18.00;3abmJ-1harA:13.37"],["3ABM_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","3abmN-1harA:undetectable;3abmW-1harA:0.0","3abmN-1harA:18.00;3abmW-1harA:13.37"],["3AG3_J_CHDJ60_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","3ag3A-1harA:undetectable;3ag3J-1harA:0.0","3ag3A-1harA:18.00;3ag3J-1harA:13.37"],["3AG3_W_CHDW1059_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.79A","3ag3N-1harA:undetectable;3ag3W-1harA:0.1","3ag3N-1harA:18.00;3ag3W-1harA:13.37"],["3ASN_J_CHDJ60_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.73A","3asnA-1harA:undetectable;3asnJ-1harA:0.1","3asnA-1harA:18.00;3asnJ-1harA:13.37"],["3ASN_W_CHDW1059_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.74A","3asnN-1harA:undetectable;3asnW-1harA:0.1","3asnN-1harA:18.00;3asnW-1harA:13.37"],["3ASO_J_CHDJ60_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","3asoA-1harA:undetectable;3asoJ-1harA:0.1","3asoA-1harA:18.00;3asoJ-1harA:13.37"],["3ASO_W_CHDW1059_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.71A","3asoN-1harA:undetectable;3asoW-1harA:0.0","3asoN-1harA:18.00;3asoW-1harA:13.37"],["3HVT_A_NVPA557_1","HIV-1 REVERSE TRANSCRIPTASE (SUBUNIT P66)","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 106;TYR A 181;TYR A 188;GLY A 190","None","1.07A","3hvtA-1harA:24.3","3hvtA-1harA:94.91"],["3LP0_A_NVPA701_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.62A","3lp0A-1harA:27.0","3lp0A-1harA:93.98"],["3LP1_A_NVPA701_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.65A","3lp1A-1harA:27.5","3lp1A-1harA:93.98"],["3MEC_A_65BA561_0","P66 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.68A","3mecA-1harA:13.0","3mecA-1harA:94.44"],["3MED_A_65BA561_0","P51 REVERSE TRANSCRIPTASE;P66 REVERSE TRANSCRIPTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.68A","3medA-1harA:27.7;3medB-1harA:10.3","3medA-1harA:93.98;3medB-1harA:93.98"],["3QIP_A_NVPA561_1","REVERSE HIV-1 REVERSE TRANSCRIPTASE P66","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.97A","3qipA-1harA:12.6","3qipA-1harA:94.44"],["3QIP_A_NVPA561_1","REVERSE HIV-1 REVERSE TRANSCRIPTASE P66","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.51A","3qipA-1harA:12.6","3qipA-1harA:94.44"],["3TJ7_C_ACTC610_0","GBAA_1210 PROTEIN","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",3,"ASN A  54;ALA A 129;ARG A 143","None","0.88A","3tj7C-1harA:0.0;3tj7D-1harA:0.0","3tj7C-1harA:19.57;3tj7D-1harA:19.57"],["4DO3_B_0LAB602_1","FATTY-ACID AMIDE HYDROLASE 1","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 168;LEU A 205;ILE A 202;THR A 216","None","0.90A","4do3B-1harA:0.9","4do3B-1harA:17.76"],["4J7U_D_YTZD802_1","SEPIAPTERIN REDUCTASE","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A  34;CYH A  38;TYR A 144;PRO A 133","None","1.20A","4j7uD-1harA:undetectable","4j7uD-1harA:20.48"],["4PUO_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"VAL A 106;VAL A 179;TYR A 181;TYR A 188","None","0.57A","4puoC-1harA:21.4","4puoC-1harA:94.91"],["4PWD_A_NVPA901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"VAL A 106;VAL A 179;TYR A 181;TYR A 188","None","0.54A","4pwdA-1harA:21.6","4pwdA-1harA:94.91"],["4PWD_C_NVPC901_1","HIV-1 REVERSE TRANSCRIPTASE, P66 SUBUNIT","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"VAL A 106;VAL A 179;TYR A 181;TYR A 188","None","0.59A","4pwdC-1harA:12.4","4pwdC-1harA:94.91"],["5B1A_J_CHDJ102_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.70A","5b1aA-1harA:undetectable;5b1aJ-1harA:0.1","5b1aA-1harA:18.00;5b1aJ-1harA:13.37"],["5B1B_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","5b1bA-1harA:undetectable;5b1bJ-1harA:0.1","5b1bA-1harA:18.00;5b1bJ-1harA:13.37"],["5B3S_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.73A","5b3sA-1harA:undetectable;5b3sJ-1harA:0.1","5b3sA-1harA:18.00;5b3sJ-1harA:13.37"],["5HBM_A_NVPA601_1","REVERSE TRANSCRIPTASE\/RIBONUCLEASE H","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",6,"LYS A 104;VAL A 106;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.88A","5hbmA-1harA:27.5","5hbmA-1harA:94.91"],["5IY5_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.73A","5iy5A-1harA:undetectable;5iy5J-1harA:0.1","5iy5A-1harA:18.00;5iy5J-1harA:13.43"],["5V0V_A_8QSA615_1","SERUM ALBUMIN","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;HIS A 198;LEU A 168;ILE A 178","None","0.95A","5v0vA-1harA:0.3","5v0vA-1harA:15.60"],["5X1F_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.76A","5x1fA-1harA:undetectable;5x1fJ-1harA:0.2","5x1fA-1harA:18.00;5x1fJ-1harA:13.37"],["5XDQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.95A","5xdqN-1harA:undetectable;5xdqW-1harA:0.0","5xdqN-1harA:18.00;5xdqW-1harA:13.37"],["5XDX_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.75A","5xdxA-1harA:undetectable;5xdxJ-1harA:0.1","5xdxA-1harA:18.00;5xdxJ-1harA:13.37"],["5XDX_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT VIIA-HEART","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","5xdxN-1harA:undetectable;5xdxW-1harA:0.0","5xdxN-1harA:18.00;5xdxW-1harA:13.37"],["5ZCO_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.73A","5zcoA-1harA:undetectable;5zcoJ-1harA:0.1","5zcoA-1harA:18.00;5zcoJ-1harA:13.37"],["5ZCP_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","5zcpA-1harA:undetectable;5zcpJ-1harA:0.1","5zcpA-1harA:18.00;5zcpJ-1harA:13.37"],["5ZCP_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.74A","5zcpN-1harA:undetectable;5zcpW-1harA:0.1","5zcpN-1harA:18.00;5zcpW-1harA:13.37"],["5ZCQ_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.70A","5zcqA-1harA:undetectable;5zcqJ-1harA:0.1","5zcqA-1harA:18.00;5zcqJ-1harA:13.37"],["5ZCQ_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.72A","5zcqN-1harA:undetectable;5zcqW-1harA:0.1","5zcqN-1harA:18.00;5zcqW-1harA:13.37"],["6BSG_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","0.87A","6bsgA-1harA:26.1","6bsgA-1harA:91.14"],["6BSI_A_EFZA601_1","REVERSE TRANSCRIPTASE P66 SUBUNIT","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",5,"LYS A 104;VAL A 179;TYR A 181;TYR A 188;GLY A 190","None","1.10A","6bsiA-1harA:24.0","6bsiA-1harA:91.14"],["6NMF_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.87A","6nmfA-1harA:undetectable;6nmfJ-1harA:0.1","6nmfA-1harA:18.00;6nmfJ-1harA:13.37"],["6NMP_J_CHDJ101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","1har","HIV-1 REVERSE TRANSCRIPTASE (FINGERS AND PALM SUBDOMAINS)","Human immunodeficiency virus 1",4,"LEU A 109;MET A 164;THR A 165;LEU A 168","None","0.96A","6nmpA-1harA:undetectable;6nmpJ-1harA:0.1","6nmpA-1harA:18.00;6nmpJ-1harA:13.37"]]